| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comprehensive review on zinc(II) complexes as anti-diabetic agents: The advances, scientific gaps and prospects
|
Chukwuma, Chika Ifeanyi
|
|
|
155 |
C |
p.
|
artikel
|
| 2 |
Acute lung injury: The therapeutic role of Rho kinase inhibitors
|
Abedi, Farshad
|
|
|
155 |
C |
p.
|
artikel
|
| 3 |
Advances in molecular mechanisms of drugs affecting abnormal glycosylation and metastasis of breast cancer
|
Liu, Huimin
|
|
|
155 |
C |
p.
|
artikel
|
| 4 |
A machine learning-driven study indicates emodin improves cardiac hypertrophy by modulation of mitochondrial SIRT3 signaling
|
Gao, Jian
|
|
|
155 |
C |
p.
|
artikel
|
| 5 |
Anti-diabetic potential of plant alkaloids: Revisiting current findings and future perspectives
|
Rasouli, Hassan
|
|
|
155 |
C |
p.
|
artikel
|
| 6 |
Arctigenin, a novel TMEM16A inhibitor for lung adenocarcinoma therapy
|
Guo, Shuai
|
|
|
155 |
C |
p.
|
artikel
|
| 7 |
A review of pharmacological and pharmacokinetic properties of stachydrine
|
Cheng, Fang
|
|
|
155 |
C |
p.
|
artikel
|
| 8 |
Astaxanthin anticancer effects are mediated through multiple molecular mechanisms: A systematic review
|
Faraone, Immacolata
|
|
|
155 |
C |
p.
|
artikel
|
| 9 |
Berberine-mediated up-regulation of surfactant protein D facilitates cartilage repair by modulating immune responses via the inhibition of TLR4/NF-ĸB signaling
|
Zhou, Yan
|
|
|
155 |
C |
p.
|
artikel
|
| 10 |
Berberine pharmacology and the gut microbiota: A hidden therapeutic link
|
Habtemariam, Solomon
|
|
|
155 |
C |
p.
|
artikel
|
| 11 |
Brain microRNAs dysregulation: Implication for missplicing and abnormal post-translational modifications of tau protein in Alzheimer’s disease and related tauopathies
|
Bazrgar, Maryam
|
|
|
155 |
C |
p.
|
artikel
|
| 12 |
Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis
|
He, Jinzhao
|
|
|
155 |
C |
p.
|
artikel
|
| 13 |
Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve pain
|
Brouillette, Rebecca L.
|
|
|
155 |
C |
p.
|
artikel
|
| 14 |
Combination of Gentiana rhodantha and Gerbera anandria in the BL02 formula as therapeutics to non-small cell lung carcinoma acting via Rap1/cdc42 signaling: A transcriptomics/ bio-informatics biological validation approach
|
Tan, Hor-Yue
|
|
|
155 |
C |
p.
|
artikel
|
| 15 |
Corrigendum to “Traditional Chinese medicine for COVID-19 treatment” [Pharmacol. Res. 155 (2020) 104743]
|
Ren, Jun-ling
|
|
|
155 |
C |
p.
|
artikel
|
| 16 |
Developing effective combination therapy for pancreatic cancer: An overview
|
Miller, Aubrey L.
|
|
|
155 |
C |
p.
|
artikel
|
| 17 |
Editorial Board
|
|
|
|
155 |
C |
p.
|
artikel
|
| 18 |
Endoplasmic reticulum stress signaling in cancer and neurodegenerative disorders: Tools and strategies to understand its complexity
|
da Silva, Daniela Correia
|
|
|
155 |
C |
p.
|
artikel
|
| 19 |
Epigenetic histone modulations of PPARγ and related pathways contribute to olanzapine-induced metabolic disorders
|
Su, Yueqing
|
|
|
155 |
C |
p.
|
artikel
|
| 20 |
Gut microbiota protects from triptolide-induced hepatotoxicity: Key role of propionate and its downstream signalling events
|
Huang, Jian-Feng
|
|
|
155 |
C |
p.
|
artikel
|
| 21 |
Human antigen R: A potential therapeutic target for liver diseases
|
Liu, Runping
|
|
|
155 |
C |
p.
|
artikel
|
| 22 |
Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy
|
Cai, Xuanyan
|
|
|
155 |
C |
p.
|
artikel
|
| 23 |
Kinin B1 receptor: A target for neuroinflammation in hypertension
|
Sriramula, Srinivas
|
|
|
155 |
C |
p.
|
artikel
|
| 24 |
MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis
|
Das, Swadesh K.
|
|
|
155 |
C |
p.
|
artikel
|
| 25 |
Mechanistic insights of adipocyte metabolism in regulating breast cancer progression
|
Zhang, Fuchuang
|
|
|
155 |
C |
p.
|
artikel
|
| 26 |
Microglia, autonomic nervous system, immunity and hypertension: Is there a link?
|
Li, You
|
|
|
155 |
C |
p.
|
artikel
|
| 27 |
MicroRNA-27a-3p aggravates renal ischemia/reperfusion injury by promoting oxidative stress via targeting growth factor receptor-bound protein 2
|
Zhao, X.-R.
|
|
|
155 |
C |
p.
|
artikel
|
| 28 |
Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy
|
Wu, Yuanlin
|
|
|
155 |
C |
p.
|
artikel
|
| 29 |
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant
|
Pelaia, Corrado
|
|
|
155 |
C |
p.
|
artikel
|
| 30 |
Overview of stimuli-responsive mesoporous organosilica nanocarriers for drug delivery
|
Guimarães, Rafaela S.
|
|
|
155 |
C |
p.
|
artikel
|
| 31 |
Panaxadiol inhibits programmed cell death-ligand 1 expression and tumour proliferation via hypoxia-inducible factor (HIF)-1α and STAT3 in human colon cancer cells
|
Wang, Zhe
|
|
|
155 |
C |
p.
|
artikel
|
| 32 |
Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence
|
Aimo, Alberto
|
|
|
155 |
C |
p.
|
artikel
|
| 33 |
Postmenopausal hormone therapy and Alzheimer's disease, dementia, and Parkinson's disease: A systematic review and time-response meta-analysis
|
Wu, Minghua
|
|
|
155 |
C |
p.
|
artikel
|
| 34 |
Pre-Eclampsia: Microbiota possibly playing a role
|
Ahmadian, Elham
|
|
|
155 |
C |
p.
|
artikel
|
| 35 |
Protective effect of ginsenoside Rg5 against kidney injury via inhibition of NLRP3 inflammasome activation and the MAPK signaling pathway in high-fat diet/streptozotocin-induced diabetic mice
|
Zhu, Yanyan
|
|
|
155 |
C |
p.
|
artikel
|
| 36 |
Protective effects of lycopene in cancer, cardiovascular, and neurodegenerative diseases: An update on epidemiological and mechanistic perspectives
|
Saini, Ramesh Kumar
|
|
|
155 |
C |
p.
|
artikel
|
| 37 |
Roles of RNF126 and BCA2 E3 ubiquitin ligases in DNA damage repair signaling and targeted cancer therapy
|
Zhang, Rou
|
|
|
155 |
C |
p.
|
artikel
|
| 38 |
Roxadustat (FG-4592) treatment for anemia in dialysis-dependent (DD) and not dialysis-dependent (NDD) chronic kidney disease patients: A systematic review and meta‐analysis
|
Liu, Junduo
|
|
|
155 |
C |
p.
|
artikel
|
| 39 |
Sex-differences in factors and outcomes associated with adherence to statin therapy in primary care: Need for customisation strategies
|
Olmastroni, Elena
|
|
|
155 |
C |
p.
|
artikel
|
| 40 |
S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer
|
Zhang, Yu-Hang
|
|
|
155 |
C |
p.
|
artikel
|
| 41 |
Statin therapy in athletes and patients performing regular intense exercise – Position paper from the International Lipid Expert Panel (ILEP)
|
Katsiki, Niki
|
|
|
155 |
C |
p.
|
artikel
|
| 42 |
Targeting obesity with plant-derived pancreatic lipase inhibitors: A comprehensive review
|
Rajan, Logesh
|
|
|
155 |
C |
p.
|
artikel
|
| 43 |
Telomerase: Key regulator of inflammation and cancer
|
Wu, Lele
|
|
|
155 |
C |
p.
|
artikel
|
| 44 |
TGF-β activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseases
|
Marafini, Irene
|
|
|
155 |
C |
p.
|
artikel
|
| 45 |
TGF-β in radiotherapy: Mechanisms of tumor resistance and normal tissues injury
|
Farhood, Bagher
|
|
|
155 |
C |
p.
|
artikel
|
| 46 |
The diverse functions of Siglec-15 in bone remodeling and antitumor responses
|
Kang, Fu-biao
|
|
|
155 |
C |
p.
|
artikel
|
| 47 |
The potential of the novel NAD+ supplementing agent, SNH6, as a therapeutic strategy for the treatment of Friedreich’s ataxia
|
Chiang, Shannon
|
|
|
155 |
C |
p.
|
artikel
|
| 48 |
Therapeutic potential of blood flow mimetic compounds in preventing endothelial dysfunction and atherosclerosis
|
Xu, Suowen
|
|
|
155 |
C |
p.
|
artikel
|
| 49 |
The role of small molecule Flt3 receptor protein-tyrosine kinase inhibitors in the treatment of Flt3-positive acute myelogenous leukemias
|
Roskoski Jr., Robert
|
|
|
155 |
C |
p.
|
artikel
|
| 50 |
The Status quo and way forwards on the development of Tibetan medicine and the pharmacological research of tibetan materia Medica
|
Fu, Ke
|
|
|
155 |
C |
p.
|
artikel
|
| 51 |
Traditional Chinese medicine for COVID-19 treatment
|
Ren, Jun-ling
|
|
|
155 |
C |
p.
|
artikel
|
| 52 |
TRAIL in oncology: From recombinant TRAIL to nano- and self-targeted TRAIL-based therapies
|
Dianat-Moghadam, Hassan
|
|
|
155 |
C |
p.
|
artikel
|
| 53 |
Urinary bladder sigma-1 receptors: A new target for cystitis treatment
|
González-Cano, Rafael
|
|
|
155 |
C |
p.
|
artikel
|
| 54 |
Venom natriuretic peptides guide the design of heart failure therapeutics
|
Sridharan, Sindhuja
|
|
|
155 |
C |
p.
|
artikel
|
Tijdschrift beschrijving